Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial In the article that accompanies this editorial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results